Prediction of particle charging in a dilute pneumatic conveying system

AICHE Journal - Tập 59 Số 7 - Trang 2308-2316 - 2013
Poom Bunchatheeravate1, Jennifer Curtis1, Yusuke Fujii2, Shuji Matsusaka2
1Dept. of Chemical Engineering, University of Florida, Gainesville, FL, 32611
2Dept. of Chemical Engineering, Kyoto University, Kyoto, 615-8510 Japan

Tóm tắt

When particles are transported in pipelines, they acquire electrostatic charges as they come into contact with the pipe wall. Charged particles can cause problems such as particle agglomeration, blockage, and explosion. Understanding the particle charge can help to prevent these issues. This study investigates a technique for predicting the particle charge in a straight pipe of any given length, as well as the pipe length at which electrostatic equilibrium occurs, through experimentation in a short 1‐m pipe section. Experimentation with five different types of particles and four pipe wall materials at longer pipe lengths were used to validate the technique. This predictive technique is applicable to a range of particle shapes and sizes under the restriction that charge transfer is due to impact charging. © 2013 American Institute of Chemical Engineers AIChE J, 59: 2308–2316, 2013

Từ khóa


Tài liệu tham khảo

10.1002/9780470727102

Henthorn KH, 2012, Particle Technology and Applications, 17

JonesTB.Electrostatic Problems in Powder Technology. NEPTIS‐3. Kyoto: Nishi Engr November 1994.

10.1109/TIA.1985.349702

10.1016/0304-3886(85)90041-5

Klinzing GE, 2003, Handbook of Fluidization and Fluid–Particle System

10.1002/prs.11530

10.1007/978-94-009-0405-7

10.1021/ie8004786

Peart J, 2003, Relevance of electrostatics in respiratory drug delivery, Business Briefing: Pharmagenerics, 84

10.14356/kona.2011022

Leong FW, 2006, Electrostatic effect on inertial particle transport in bifurcated tubes, AIChE J., 61, 2262

10.1016/j.ces.2005.05.006

10.1016/j.ces.2007.07.010

10.1063/1.3665207

10.1088/0957-0233/7/12/012

10.1016/j.ces.2005.05.007

10.1002/aic.12638

10.1016/S0032-5910(03)00159-1

10.1002/aic.690220320

10.1016/0032-5910(82)85036-5

10.1002/aic.10991

10.1016/0304-3886(95)00018-6

10.1016/0304-3886(88)90021-6

10.1088/0022-3727/33/18/316

10.1016/S0921-8831(08)60529-4

10.1016/j.ijpharm.2006.11.005

10.1016/S0304-3886(01)00185-1

10.1163/156855207780208673

10.4164/sptj.45.380

10.14356/kona.2011007

10.1002/anie.201200057

10.1002/anie.201202896

10.1021/la00028a021

10.1002/anie.200701812

10.1021/ja300925h

10.1021/jp306261k

10.1016/S0304-3886(97)00009-0

10.1016/j.ces.2010.07.005

10.1016/S0304-3886(96)00026-5